PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-40.74%
Negative net income growth while ZETA stands at 40.68%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-8.54%
Both reduce yoy D&A, with ZETA at -1.61%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-16516.67%
Negative yoy deferred tax while ZETA stands at 53.19%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
186.92%
Working capital change of 186.92% while ZETA is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
320.96%
Growth well above ZETA's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-114.12%
Both negative yoy, with ZETA at -192.80%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
33.59%
Operating cash flow growth above 1.5x ZETA's 20.83%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-2.99%
Negative yoy CapEx while ZETA is 14.14%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
100.00%
Some acquisitions while ZETA is negative at -26.79%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
9.03%
Purchases growth of 9.03% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-2.00%
We reduce yoy sales while ZETA is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
48.00%
We have mild expansions while ZETA is negative at -18.84%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-72.81%
Negative yoy issuance while ZETA is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
30.14%
We have some buyback growth while ZETA is negative at -23.83%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.